The Health Ministry will allow registrations for cannabis-based medication if there is solid evidence the product can be used safely and effectively to treat patients, Health Minister Khairy Jamaluddin said.

The Institute for Clinical Research (ICR) under the National Health Institute, he said, was conducting reviews and discussions with experts, especially in the fields of ecology and palliative care.